vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Huron Consulting Group Inc. (HURN). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $442.0M, roughly 1.9× Huron Consulting Group Inc.). Huron Consulting Group Inc. runs the higher net margin — 6.9% vs 0.5%, a 6.4% gap on every dollar of revenue. On growth, Huron Consulting Group Inc. posted the faster year-over-year revenue change (10.7% vs 7.5%). Over the past eight quarters, Huron Consulting Group Inc.'s revenue compounded faster (10.3% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Huron Consulting Group, commonly known as Huron, is a management consulting firm offering services to the healthcare, life sciences, commercial, and higher education industries.
ACHC vs HURN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $442.0M |
| Net Profit | $4.5M | $30.7M |
| Gross Margin | — | — |
| Operating Margin | — | 11.4% |
| Net Margin | 0.5% | 6.9% |
| Revenue YoY | 7.5% | 10.7% |
| Net Profit YoY | -50.8% | -9.8% |
| EPS (diluted) | $0.05 | $1.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $442.0M | ||
| Q3 25 | $851.6M | $441.3M | ||
| Q2 25 | $869.2M | $411.8M | ||
| Q1 25 | $770.5M | $404.1M | ||
| Q4 24 | $774.2M | $399.3M | ||
| Q3 24 | $815.6M | $378.1M | ||
| Q2 24 | $796.0M | $381.0M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $30.7M | ||
| Q3 25 | $36.2M | $30.4M | ||
| Q2 25 | $30.1M | $19.4M | ||
| Q1 25 | $8.4M | $24.5M | ||
| Q4 24 | $32.6M | $34.0M | ||
| Q3 24 | $68.1M | $27.1M | ||
| Q2 24 | $78.5M | $37.5M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 11.4% | ||
| Q3 25 | 4.7% | 11.3% | ||
| Q2 25 | 5.8% | 11.1% | ||
| Q1 25 | 1.7% | 8.1% | ||
| Q4 24 | 4.9% | 11.8% | ||
| Q3 24 | 12.1% | 11.2% | ||
| Q2 24 | 13.4% | 15.6% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 6.9% | ||
| Q3 25 | 4.3% | 6.9% | ||
| Q2 25 | 3.5% | 4.7% | ||
| Q1 25 | 1.1% | 6.1% | ||
| Q4 24 | 4.2% | 8.5% | ||
| Q3 24 | 8.4% | 7.2% | ||
| Q2 24 | 9.9% | 9.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.71 | ||
| Q3 25 | $0.40 | $1.71 | ||
| Q2 25 | $0.33 | $1.09 | ||
| Q1 25 | $0.09 | $1.33 | ||
| Q4 24 | $0.36 | $1.82 | ||
| Q3 24 | $0.74 | $1.47 | ||
| Q2 24 | $0.85 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $24.5M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $528.6M |
| Total Assets | $5.5B | $1.5B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $24.5M | ||
| Q3 25 | $118.7M | $23.9M | ||
| Q2 25 | $131.4M | $61.0M | ||
| Q1 25 | $91.2M | $23.4M | ||
| Q4 24 | $76.3M | $21.9M | ||
| Q3 24 | $82.1M | $18.5M | ||
| Q2 24 | $77.2M | $17.6M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $528.6M | ||
| Q3 25 | $3.1B | $499.8M | ||
| Q2 25 | $3.1B | $475.0M | ||
| Q1 25 | $3.0B | $494.3M | ||
| Q4 24 | $3.1B | $561.3M | ||
| Q3 24 | $3.0B | $522.8M | ||
| Q2 24 | $3.0B | $500.6M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $1.5B | ||
| Q3 25 | $6.4B | $1.5B | ||
| Q2 25 | $6.3B | $1.5B | ||
| Q1 25 | $6.1B | $1.4B | ||
| Q4 24 | $6.0B | $1.3B | ||
| Q3 24 | $5.9B | $1.3B | ||
| Q2 24 | $5.7B | $1.3B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $126.4M |
| Free Cash FlowOCF − Capex | — | $123.8M |
| FCF MarginFCF / Revenue | — | 28.0% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | 13.78× | 4.12× |
| TTM Free Cash FlowTrailing 4 quarters | — | $183.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $126.4M | ||
| Q3 25 | $73.2M | $93.8M | ||
| Q2 25 | $133.5M | $80.0M | ||
| Q1 25 | $11.5M | $-106.8M | ||
| Q4 24 | $116.7M | $139.6M | ||
| Q3 24 | $163.1M | $85.2M | ||
| Q2 24 | $171.1M | $107.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $123.8M | ||
| Q3 25 | $-63.0M | $89.8M | ||
| Q2 25 | $-34.2M | $78.0M | ||
| Q1 25 | $-163.2M | $-108.7M | ||
| Q4 24 | $-86.8M | $137.0M | ||
| Q3 24 | $-27.1M | $82.8M | ||
| Q2 24 | $16.9M | $104.7M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 28.0% | ||
| Q3 25 | -7.4% | 20.3% | ||
| Q2 25 | -3.9% | 18.9% | ||
| Q1 25 | -21.2% | -26.9% | ||
| Q4 24 | -11.2% | 34.3% | ||
| Q3 24 | -3.3% | 21.9% | ||
| Q2 24 | 2.1% | 27.5% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.6% | ||
| Q3 25 | 16.0% | 0.9% | ||
| Q2 25 | 19.3% | 0.5% | ||
| Q1 25 | 22.7% | 0.5% | ||
| Q4 24 | 26.3% | 0.7% | ||
| Q3 24 | 23.3% | 0.6% | ||
| Q2 24 | 19.4% | 0.6% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 4.12× | ||
| Q3 25 | 2.02× | 3.08× | ||
| Q2 25 | 4.43× | 4.12× | ||
| Q1 25 | 1.37× | -4.35× | ||
| Q4 24 | 3.58× | 4.11× | ||
| Q3 24 | 2.39× | 3.14× | ||
| Q2 24 | 2.18× | 2.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
HURN
| Consulting And Managed Services Capability | $172.9M | 39% |
| Education | $118.7M | 27% |
| Commercial | $91.9M | 21% |
| Digital Capability | $54.6M | 12% |
